InvestorsHub Logo
Followers 798
Posts 50894
Boards Moderated 2
Alias Born 12/12/2004

Re: dinogreeves post# 30

Monday, 04/06/2020 9:03:35 AM

Monday, April 06, 2020 9:03:35 AM

Post# of 96
VIR > GlaxoSmithKline To Make $250M Equity Investment In Vir
8:05 am ET April 6, 2020 (Benzinga) VIR up 29% 37.62
Companies will combine their unique scientific and technical expertise to combat COVID-19 and potential future coronavirus outbreaks


Promising antibody candidates for SARS-CoV-2 to be accelerated into phase 2 clinical trials within the next three to five months


GSK to make equity investment of $250 million in Vir
LONDON and SAN FRANCISCO, April 06, 2020 (GLOBE NEWSWIRE) -- LSE announcement -- GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology, Inc. (NASDAQ:VIR) today announced they have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VIR News